Disease relevance of Bronchial Diseases

• This raises the possibility that anti-BPI antibodies contributed to both the bronchial disease and vasculitis [1].
• AIM: To define the prevalence and the characteristics of bronchial disease (wheezing, bronchial hyperreactivity [BHR], and asthma) present in subjects inhaling heroin mixed with cocaine vaporized on aluminum foil [2].

High impact information on Bronchial Diseases

• Abrogation of MRP-14 activity with a specific antibody also reduced the IL-8-stimulating potential of bronchial secretions, suggesting it was a significant stimulus to IL-8 production in the lung and may amplify the neutrophilic inflammation seen in bronchial disease [3].
• The small pulmonary nodules in seven, TNM stage of large intrapulmonary tumors in eight, and benign bronchial disease in five patients were evaluated [4].
• High enzymatic activities were observed in patients with CF who have advanced bronchial disease (that had been determined by a clinical scoring system) [5].
• Sputum and serum piperacillin levels were obtained from eight patients with bronchial disease receiving a five to seven day course (8 to 16 g/day) [6].
• Neutrophil elastase is capable of generating many of the features of chronic bronchial disease [7].

Chemical compound and disease context of Bronchial Diseases

• Twenty patients with chronic bronchial disease were treated for two separate acute bacterial exacerbations, once with 2 gm of ampicillin daily, and once with 600 mg of methacycline daily, for 14 days [8].
• The results provide a rational basis for determination of an optimal dose schedule for oral treatment with choline theophyllinate to reduce the symptoms of obstructive bronchial disease [9].
• These data demonstrate that nebivolol respect the other beta-blockers used in this study, does not significantly affect the airway responsiveness, therefore it could be used in patients with both cardiovascular and bronchial diseases more safely than other beta-blockers drugs [10].
• No demonstrable effect of sobrerol as an expectorant in patients with stable chronic bronchial diseases [11].
• Treatment of bronchial diseases in pediatrics. results of the use of oral acetylcysteine in 80 cases [12].

Gene context of Bronchial Diseases

• Aspiration of solid food particles into lungs of patients with gastroesophageal reflux and chronic bronchial disease [13].
• In a population of over 200 patients with atopic bronchial disease, significantly increased frequencies of the alpha 1-antitrypsin Pi-types of intermediate deficiency (Pi MZ and Pi MS) were found [14].

Analytical, diagnostic and therapeutic context of Bronchial Diseases

• A randomized double-blind cross-over study compared the clinical effectiveness of a 14-day treatment with 400 mg X day-1 of sobrerol and placebo in 23 patients with stable chronic bronchial disease [11].

References